NDC 59572-711 – Reblozyl
Luspatercept 25 mg/1 · Injection, Powder, Lyophilized, For Solution · Subcutaneous
Product NDC59572-711
Product details
- Brand name
- Reblozyl
- Generic name
- Luspatercept
- Labeler
- Celgene Corporation
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761136
- Marketed since
- November 8, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Erythroid Maturation Agent
Active ingredients
- Luspatercept 25 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 59572-711-01 | 1 VIAL, GLASS in 1 CARTON (59572-711-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS | Nov 8, 2019 |
Other Reblozyl products
- 59572-775 Luspatercept 75 mg/1 · Injection, Powder, Lyophilized, For Solution · Celgene Corporation